Cours international

5th Course in vivo Preclinical Assays in Cancer Therapy - 2012

For the fifth year, the  European  course  of  ‘in  vivo  Preclinical  Assays  in  Cancer  Therapy’ is  jointly organized with the NKI in Amsterdam. The Symposium on Preclinical Assays in Cancer Therapy is an extensive training program designed to educate and update the biomedical research community on current  trends  and  technological  advances  in vivo  preclinical  assays  in  cancer. 

Organizers: Sven Rottenberg (NKI), Jos Jonkers (NKI), Elisabetta Marangoni (Institut Curie), Virginie Dangles-Marie (Institut Curie)

The course will be open to PhD, post-docs and confirmed researchers from private and academic research.

Selection on the first-come, first-served basis.

26 - 28 septembre 2012
1 September 2012

Amsterdam, Netherlands Cancer Institute (Amphithéatre Piet Borst Auditorium)

Academic : 300 €
Industry : 450 €

Sven Rottenberg (NKI)
Jos Jonkers (NKI)
Elisabetta Marangoni (Institut Curie)
Virginie Dangles-Marie (Institut Curie)

The emphasis of this course will be on the use of genetically engineered mouse models and patient-derived xenograft (PDX) models for in vivo preclinical research, but also in vitro preclinical assays employing established tumor cell lines and functional genomics approaches will be discussed.
The course will also cover the following topics: humanized mouse models, preclinical imaging, angiogenesis and metastasis in vivo, therapy resistance models and approaches, regulatory animal requirement, ethics and co-clinical trials.

The course will include a 3-day course, with presentations from national and international experts.